ClinicalTrials.Veeva

Menu

Cognitive Intervention For Delirium in Dementia

The Pennsylvania State University (PENNSTATE) logo

The Pennsylvania State University (PENNSTATE)

Status and phase

Completed
Phase 2

Conditions

Delirium
Dementia

Treatments

Behavioral: Cognitive Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT01267682
R01NR012242

Details and patient eligibility

About

The purpose of this study is to test the effectiveness of cognitively stimulating activities for resolving delirium in people with dementia.

Full description

The primary aim in this RCT is to test the efficacy of Recreational Stimulation for Elders as a Vehicle to resolve DSD (RESERVE- DSD). The investigators will randomize 256 subjects, newly admitted to post acute care, to intervention (RESERVE-DSD) or control (usual care). Intervention subjects will receive 30-minute sessions of tailored cognitively stimulating recreational activities for up to 30 days. The investigators hypothesize that subjects who receive RESERVE-DSD will have: decreased severity and duration of delirium; greater gains in attention, orientation, memory, abstract thinking, and executive functioning; and greater gains in physical function compared to subjects with DSD who receive usual care. The investigators will also evaluate potential moderators of intervention efficacy (lifetime of complex mental activities and APOE status). The secondary aim is to describe the costs associated with RESERVE-DSD.

Enrollment

283 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • presence of delirium
  • mild to moderate cognitive impairments
  • 65 years of age or older
  • English speaking
  • community-dwelling
  • legally authorized representative available

Exclusion criteria

  • severe vision or hearing problems

  • diagnosis of

    1. major depression
    2. Parkinson's with Lewy Body disease
    3. Huntington's disease
    4. normal pressure hydrocephalus
    5. seizure disorder
    6. subdural hematoma
    7. head trauma
    8. known structural brain abnormalities
    9. acute CVA/stroke
    10. acute psychiatric condition
  • life expectancy < 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

283 participants in 2 patient groups

Usual care
No Intervention group
Description:
Participants receive standard clinical care
Treatment
Experimental group
Description:
Behavioral: cognitive stimulation
Treatment:
Behavioral: Cognitive Stimulation

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems